-transparent.png){kind=logo}
The antimicrobial drug 1-methyl-2-nitro-5-vinylimidazole (MEV) preferentially blocked DNA synthesis, was mutagenic and induced coliphage lambda in Escherichia coli. The antibacterial effects of MEV are the consequences of repairable damage to DNA, as shown by hypersensitivity of recA and uvr strains to MEV and related drugs, stimulation by MEV of DNA turnover which was dependent on the product of the uvrA gene, and the presence of cross-links in DNA from MEV-treated bacteria.
Related Publications
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
January 1978,
Il Farmaco; edizione scientifica,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
June 1977,
Journal of general microbiology,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
October 1972,
Journal of medicinal chemistry,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
February 1975,
Journal of medicinal chemistry,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
October 1997,
Bioorganic & medicinal chemistry,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
March 1973,
Biochemical pharmacology,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
December 1968,
Science (New York, N.Y.),
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
October 1982,
Journal of medicinal chemistry,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
January 1968,
Antimicrobial agents and chemotherapy,
B P Goldstein, and
E Nielsen, and
M Berti, and
G Bolzoni, and
L G Silvestri
February 2010,
Acta crystallographica. Section E, Structure reports online,
